PATENT CLAIM ANALYSIS

Application Number: 15940215
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 5):
The enucleated erythroid cell of  claim 3 , wherein the exogenous nucleic acid comprises a lentiviral vector comprising a nucleic acid sequence encoding the exogenous polypeptide.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15783921', '15925212', '15824877', '15473421', '14738414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7002905407361407
- 35 USC 102 Novelty (BERT): 0.621497513268157
- Combined Prediction Score: 0.6924112379893423
- Mean Citation Score: 570.989058
- Max Citation Score: 592.26404
- Similarity Product: 510.6208383686256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test